Steve Schonfeld’s GeneDx Holdings WGS Stock Holding History

Steve Schonfeld’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$695K	Sell	10,122 -21,983	-68%	-$1.25M	﹤0.01%	1680
2026 Q1	$2.06M	Buy	32,105 +14,767	+85%	+$1.35M	0.01%	810
2025 Q4	$2.25M	Buy	17,338 +4,311	+33%	+$592K	0.01%	832
2025 Q3	$1.4M	Sell	13,027 -159,356	-92%	-$17.4M	0.01%	1214
2025 Q2	$15.9M	Buy	+172,383	New	+$13.5M	0.11%	220
2022 Q1	–	Sell	-7,116	Closed	-$1.05M	–	2953
2021 Q4	$1.05M	Buy	7,116 +3,277	+85%	+$732K	0.01%	918
2021 Q3	$962K	Buy	+3,839	New	+$1.32M	0.01%	976
2021 Q2	–	Sell	-4,130	Closed	-$2.03M	–	2351
2021 Q1	$2.03M	Buy	+4,130	New	+$2.15M	0.02%	653

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Steve Schonfeld's WGS Position: Q2 2026 in Review

Steve Schonfeld reduced its GeneDx Holdings (WGS) stake by 68% in Q2 2026, selling an estimated $1.25M and leaving 10,122 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Steve Schonfeld first reported a position in WGS in Q1 2021 and has held it in 8 quarters since. The position peaked at $15.9M in Q2 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Steve Schonfeld held 10,122 shares of GeneDx Holdings worth $695K as of Q2 2026.
Steve Schonfeld sold 21,983 GeneDx Holdings shares in Q2 2026, an estimated $1.25M.
GeneDx Holdings made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1680 holding.
Steve Schonfeld first reported a position in GeneDx Holdings in Q1 2021 and has held it in 8 quarters since.
Steve Schonfeld's GeneDx Holdings position peaked at $15.9M in Q2 2025.
222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.